¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, Á¦Çüº°, À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°
Dry Eye Products Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Dosage Form, Type, Distribution Channel, and Geography
»óǰÄÚµå : 1482330
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 217 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,368,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 9,231,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 12,093,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

´ç»çÀÇ ÃֽŠÁ¶»ç º¸°í¼­ "2031³â±îÁö °Ç¼º¾È Á¦Ç° ½ÃÀå ¿¹Ãø - ¼¼°è ºÐ¼® - Á¦Ç°º°, Á¦Çüº°, À¯Çüº°, À¯Åë ä³Îº°"¿¡ µû¸£¸é, 2023³â ½ÃÀå ±Ô¸ð´Â 69¾ï 5,000¸¸ ´Þ·¯À̸ç, 2030³â¿¡´Â 100¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2023-2031³â CAGRÀº 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¾È±¸°ÇÁ¶ÁõÀº ¾È±¸ÀÇ À±È°°ú ¿µ¾ç °ø±ÞÀ» À§ÇØ ÃæºÐÇÑ ¾çÀÇ ´«¹°ÀÌ ¾ø°Å³ª ´«¹°ÀÌ »¡¸® Áõ¹ßÇÏ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â Áõ»óÀÔ´Ï´Ù. È£¸£¸óÀÇ º¯È­·Î ÀÎÇØ ³ªÀ̰¡ µé¸é ´«¹° ºÐºñ·®ÀÌ °¨¼ÒÇÕ´Ï´Ù. ¾È±¸°ÇÁ¶ÁõÀº ³²¼º°ú ¿©¼º ¸ðµÎ¿¡°Ô ÈçÇÏ°Ô ³ªÅ¸³³´Ï´Ù. ÇÏÁö¸¸ ÁÖ·Î Æó°æ±â¿¡ Á¢¾îµç ¿©¼º¿¡°Ô ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù. ¾È±¸°ÇÁ¶ÁõÀº ¸¸¼ºÁúȯÀ¸·Î Ưȿ¾àÀº ¾øÁö¸¸, Ä¡·á¸¦ ÅëÇØ Áõ»óÀ» Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù.

¾È±¸°ÇÁ¶Áõ(DED)Àº ¾È°ú¸¦ ã´Â °¡Àå ÈçÇÑ ÀÌÀ¯ Áß ±¼ÀýÀÌ»ó, ¹é³»Àå¿¡ ÀÌ¾î °¢°¢ 3À§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾È±¸°ÇÁ¶ÁõÀÇ À¯º´·üÀº ƯÈ÷ ¼±Áø±¹¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾È±¸°ÇÁ¶ÁõÀº ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ¹ß»ýÇϸç, ºÒÆíÇÔ, ÀÚ±Ø, ½Ã·Â Àå¾Ö¸¦ À¯¹ßÇÕ´Ï´Ù. ¹Ì±¹ ¾È°úÇÐȸ(American Academy of Ophthalmology)°¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é DED´Â Àü ¼¼°è 11¸í Áß 1¸íÀÌ ¾Î°í ÀÖÀ¸¸ç, À¯º´·üÀº ´Ù¾çÇÑ ¿¬·É´ë¿¡¼­ 5%¿¡¼­ 50%¿¡ À̸£´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ÀÌ Áúº´Àº Àü ¼¼°èÀûÀ¸·Î 7¾ï 1,900¸¸ ¸í, ¹Ì±¹¿¡¼­ 3,800¸¸ ¸íÀÌ ¾Î°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ È­¸é »ç¿ëÀÇ Áõ°¡´Â Àü ¼¼°è È­¸é »ç¿ëÀÚÀÇ 26-70%°¡ ¾Î°í ÀÖ´Â ÄÄÇ»ÅÍ ½Ã°¢ ÁõÈıº(µðÁöÅÐ ´«ÀÇ ÇÇ·Î)ÀÇ Áõ°¡¿Í °ü·ÃÀÌ ÀÖÀ» ¼ö ÀÖÀ¸¸ç, DEDÀÇ À¯º´·üÀº ÁÖ¿ä Àα¸ Åë°èÇÐÀû ±×·ì Áß ¿©¼º°ú ¾Æ½Ã¾ÆÀο¡¼­ ´õ ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

´ç´¢¸Á¸·º´ÁõÀ¸·Î ÀÎÇÑ ¸Á¸·ÀÇ ÁøÇ༺ Àå¾Ö´Â DED¸¦ ´õ¿í À¯¹ßÇÕ´Ï´Ù. ¹Ì±¹ ¾È°úÇÐȸ(American Academy of Ophthalmology)°¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é, 2030³â±îÁö Àü ¼¼°èÀûÀ¸·Î 1¾ï 9,100¸¸ ¸íÀÌ ´ç´¢¸Á¸·º´Áõ¿¡ °É¸± °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2021³â ¾à 960¸¸ ¸í(Àü ¿¬·ÉÃþ)ÀÌ ´ç´¢¸Á¸·º´ÁõÀ» ¾Î°í ÀÖ½À´Ï´Ù. ÀÌó·³ ´ç´¢¸Á¸·º´Áõ À¯º´·üÀÇ Áõ°¡´Â ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¦Ç°º°, °Ç¼º¾È Á¦Ç° ½ÃÀå ±â¹Ý ÀλçÀÌÆ®

¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀåÀº Á¦Ç°º°·Î Àΰø´«¹°, Ç׿°ÁõÁ¦, ºñ°­ Á¡¾ÈÁ¦, ºÐºñ ÃËÁøÁ¦, °æ±¸¿ë ¿À¸Þ°¡ º¸ÃæÁ¦, ±âŸ·Î ºÐ·ùµË´Ï´Ù. Àΰø´«¹° ºÎ¹®Àº 2023³â ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Ç׿°ÁõÁ¦ ºÎ¹®Àº 2023-2031³â °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾È±¸ °ÇÁ¶ÁõÀº ´«¹°ÀÌ Àû°Ô ºÐºñµÇ°Å³ª ´«¿¡ ÀûÀýÇÑ Ç°ÁúÀÇ ´«¹°¸·ÀÌ ¾ø±â ¶§¹®¿¡ ¹ß»ýÇÕ´Ï´Ù. ´«¹° ºÎÁ·À¸·Î ÀÎÇÑ ´«ÀÇ À±È° ºÎÁ·Àº ¾È±¸°ÇÁ¶ÁõÀ¸·Î À̾îÁý´Ï´Ù. Àΰø´«¹°Àº ´«ÀÇ ¿ÜºÎ Ç¥¸éÀÇ ¼öºÐ·®À» Àß À¯ÁöÇÏ¿© ´«ÀÇ À±È°À» µ½½À´Ï´Ù. Àΰø´«¹°Àº ÀϹÝÀûÀ¸·Î ½ÃÆÇµÇ°í ÀÖ½À´Ï´Ù. Àΰø´«¹°(Á¡¾È¾×)Àº ¹æºÎÁ¦ Æ÷ÇÔ°ú ¹æºÎÁ¦ ¹ÌÆ÷ÇÔ µÎ °¡Áö Á¾·ù°¡ ÀÖ½À´Ï´Ù. »ç¿ë ºóµµ¿¡ µû¶ó ±ÇÀåµÇ´Â Àΰø´«¹°À» ¼±ÅÃÇØ¾ß ÇÕ´Ï´Ù. Àΰø´«¹°¿¡´Â Á© ÇüÅÂ¿Í Á© Àμ­Æ® ÇüÅÂÀÇ Àΰø´«¹°ÀÌ ÀÖ½À´Ï´Ù. ÀÌ Á¦Ç°µéÀº ´«ºÎ½É°ú °°Àº ºÎÀÛ¿ëÀÌ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù.

¾È±¸°ÇÁ¶Áõ Ä¡·áÁ¦ ½ÃÀå À¯Çüº° ÀλçÀÌÆ®

Á¦Ç° À¯Çüº°·Î ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀåÀº OTC¿Í ó¹æÀüÀ¸·Î ³ª´µ¸ç, 2023³â¿¡´Â OTC ºÎ¹®ÀÌ 2023-2031³â ¿¬Æò±Õ 5.1%ÀÇ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ȯÀÚµéÀº ÀϹÝÀǾàǰÀ¸·Î ¿øÇÏ´Â È¿°ú¸¦ ¾òÁö ¸øÇÒ °æ¿ì ¾È°ú Àǻ縦 ã´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ó¹æµÇ´Â ´ëºÎºÐÀÇ ¾È±¸°ÇÁ¶Áõ Ä¡·áÁ¦´Â ¹ÚÅ׸®¾ÆÀÇ ¹ø½ÄÀ» ¹æÁöÇϰí À¯Åë±âÇÑÀ» ¿¬ÀåÇϱâ À§ÇØ ¹æºÎÁ¦°¡ ÷°¡µÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ó¹æ ¾È¾àÀº DED ¹× ³ì³»Àå ȯÀÚÀÇ ¾È¾Ð °­ÇÏ¿Í °°Àº Áúº´À» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

American Academy of Ophthalmology(¹Ì±¹ ¾È°úÇÐȸ), World Health Organization(¼¼°èº¸°Ç±â±¸)Àº ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå¿¡ ´ëÇÑ º¸°í¼­¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ ÁÖ¿ä 2Â÷ Á¤º¸ Áß ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå »óȲ

Á¦5Àå ¾È±¸°ÇÁ¶Áõ ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå ¾È±¸°ÇÁ¶Áõ °ü·Ã Á¦Ç° ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

Á¦7Àå ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå ºÐ¼® - Á¦Ç°º°

Á¦8Àå ¾È±¸°ÇÁ¶Áõ Ä¡·á ½ÃÀå ºÐ¼® - Á¦Çüº°

Á¦9Àå ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå ºÐ¼® - Á¦Ç° À¯Çüº°

Á¦10Àå ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå ºÐ¼® - À¯Åë ä³Îº°

Á¦11Àå ¾È±¸°ÇÁ¶Áõ Á¦Ç° ½ÃÀå - Áö¿ªº° ºÐ¼®

Á¦12Àå ¾÷°è »óȲ

Á¦13Àå ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

According to our latest study on "Dry Eye Products Market Forecast to 2031 - Global Analysis - by Product, Dosage Form, Type, and Distribution Channel" the market was valued at US$ 6.95 billion in 2023 and is expected to reach US$ 10.04 billion by 2030. It is estimated to register a CAGR of 4.7% from 2023 to 2031.

Dry eye is a condition characterized by the lack of adequate quality of tears to lubricate and nourish the eye or by a quick evaporation of tears. With hormonal changes, as people get older, the tendency to produce tears decreases. Dry eye is common in both males and females. However, more cases are recorded in women, mainly those who have gone through menopause. Dry eye is a chronic condition that doesn't have a specific cure, but treatments can help manage the symptoms.

Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors and cataracts, respectively. The prevalence of dry eye is particularly rising in developed nations. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to an article published by the American Academy of Opthalmology, DED affects approximately 1 in 11 people worldwide, with prevalence ranging from 5% to 50% at various ages. According to a press release by Alcon in 2022, the disease affects ~719 million people globally and ~38 million people in the US. Moreover, the increasing use of digital screens can be associated with a rise in computer vision syndrome (digital eye strain) cases, affecting 26-70% of screen users globally. The prevalence of DED is higher in women and the Asian population among the major demographic groups.

Pprogressive damage caused to the retina due to diabetic retinopathy further results in DED. According to an article published by the American Academy of Ophthalmology, ~191.0 million people globally are estimated to suffer from diabetic retinopathy by 2030. As per the Centers for Disease Control and Prevention (CDC), approximately 9.6 million people (across all ages) in the US were living with diabetic retinopathy in 2021. Thus, the increasing incidence of diabetic retinopathy is driving the growth of the dry eye products market.

By Product, Dry Eye Products Market-Based Insights

The dry eye products market, by product, is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest dry eye products market share in 2023. The anti-inflammatory drugs segment is anticipated to register the highest CAGR during 2023-2031. The dryness of eyes is a result of the low level of tear production or the lack of the right-quality tear film in the eye. The lack of lubrication of eyes, mostly due to the insufficiency of tears, leads to the dryness of eyes. Artificial tears help maintain good moisture content on the outer surface of eyes, subsequently lubricating them. They are generally available as over-the-counter products. Artificial tears, or eye drops, are available in two forms: with preservatives and without preservatives. These are recommended based on the frequency of use. Artificial tears are also available in gel and gel insert forms. These products may have side effects such as blurred vision.

By Type, Dry Eye Products Market -Based Insights

In terms of type, the dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger share of the market in 2023, and it is anticipated to register a higher CAGR of 5.1% during 2023-2031. Patients tend to visit ophthalmologists when OTC drugs fail to produce the desired effects. Most of the prescription dry eye products contain preservatives that are added to enable a longer shelf life by preventing bacterial growth. Further, prescription eye drops are used to treat disorders such as DED and the lowering of intraocular pressure (IOP) in glaucoma patients.

American Academy of Opthalmology, and World Health Organization are a few of the major secondary sources referred to while preparing the report on the dry eye products market.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Dry Eye Products Market Landscape

5. Dry Eye Products Market - Key Market Dynamics

6. Dry Eye Products Market - Global Market Analysis

7. Dry Eye Products Market Analysis - by Product

8. Dry Eye Products Market Analysis - by Dosage Form

9. Dry Eye Products Market Analysis - by Type

10. Dry Eye Products Market Analysis - by Distribution Channel

11. Dry Eye Products Market - Geographical Analysis

12. Industry Landscape

13. Company Profiles

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â